ATH 0.00% 0.3¢ alterity therapeutics limited

PBT434 inhibits alpha- synuclein in the brain., page-21

  1. 5,925 Posts.
    lightbulb Created with Sketch. 151
    This may help. [The affinity of PBT434 for iron is greater than that of alpha-synuclein but lower than that of endogenous iron trafficking proteins, e.g., ferritin.]
    https://www.mdsabstracts.org/abstract/pbt434-prevents-the-accumulation-of-glial-cell-inclusions-and-insoluble-alpha-synuclein-in-a-mouse-model-of-multiple-system-atrophy/
    So tightly bound stores of iron are not touched by PBT434. Only free and lightly attached iron is effected by PBT434. By that MOA PBT434 is able to remove the problem iron with no chance of causing undesirable effects of clawing iron from tightly held iron stores like ferritin.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $3.516K 1.112M

Buyers (Bids)

No. Vol. Price($)
75 108230584 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 151421887 64
View Market Depth
Last trade - 13.21pm 06/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.